TCMD Quote, Financials, Valuation and Earnings

Perspective Therapeutics, Inc. has a net margin of 9.57% compared to Tactile Systems Technology, Inc.'s net margin of -12425.36%. Tactile Systems Technology, Inc.'s return on equity of 8.82% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.

Tactile Systems Technology, Inc. has a consensus price target of $18.83, signalling downside risk potential of -18.28%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 349.19%. Given that Perspective Therapeutics, Inc. has higher upside potential than Tactile Systems Technology, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Tactile Systems Technology, Inc..

Tactile Systems Technology, Inc. has a beta of 0.931, which suggesting that the stock is 6.902% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.

Tactile Systems Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.

Tactile Systems Technology, Inc. quarterly revenues are $85.8M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Tactile Systems Technology, Inc.'s net income of $8.2M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Tactile Systems Technology, Inc.'s price-to-earnings ratio is 37.92x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology, Inc. is 2.21x versus 190.87x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of 9.57% compared to Tactile Systems Technology, Inc.'s net margin of -862.39%. Tactile Systems Technology, Inc.'s return on equity of 8.82% beat VolitionRX Ltd.'s return on equity of --.

Tactile Systems Technology, Inc. has a consensus price target of $18.83, signalling downside risk potential of -18.28%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 773.02%. Given that VolitionRX Ltd. has higher upside potential than Tactile Systems Technology, Inc., analysts believe VolitionRX Ltd. is more attractive than Tactile Systems Technology, Inc..

Tactile Systems Technology, Inc. has a beta of 0.931, which suggesting that the stock is 6.902% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Tactile Systems Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Tactile Systems Technology, Inc. quarterly revenues are $85.8M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Tactile Systems Technology, Inc.'s net income of $8.2M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Tactile Systems Technology, Inc.'s price-to-earnings ratio is 37.92x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology, Inc. is 2.21x versus 17.27x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of 9.57% compared to Tactile Systems Technology, Inc.'s net margin of -1037.17%. Tactile Systems Technology, Inc.'s return on equity of 8.82% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Tactile Systems Technology, Inc. has a consensus price target of $18.83, signalling downside risk potential of -18.28%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 2034.9%. Given that Catheter Precision, Inc. has higher upside potential than Tactile Systems Technology, Inc., analysts believe Catheter Precision, Inc. is more attractive than Tactile Systems Technology, Inc..

Tactile Systems Technology, Inc. has a beta of 0.931, which suggesting that the stock is 6.902% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

Tactile Systems Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Tactile Systems Technology, Inc. quarterly revenues are $85.8M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Tactile Systems Technology, Inc.'s net income of $8.2M is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Tactile Systems Technology, Inc.'s price-to-earnings ratio is 37.92x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology, Inc. is 2.21x versus 8.37x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of 9.57% compared to Tactile Systems Technology, Inc.'s net margin of 3.93%. Tactile Systems Technology, Inc.'s return on equity of 8.82% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Tactile Systems Technology, Inc. has a consensus price target of $18.83, signalling downside risk potential of -18.28%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 92.8%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Tactile Systems Technology, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Tactile Systems Technology, Inc..

Tactile Systems Technology, Inc. has a beta of 0.931, which suggesting that the stock is 6.902% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Tactile Systems Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Tactile Systems Technology, Inc. quarterly revenues are $85.8M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Tactile Systems Technology, Inc.'s net income of $8.2M is higher than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Tactile Systems Technology, Inc.'s price-to-earnings ratio is 37.92x while Xtant Medical Holdings, Inc.'s PE ratio is 76.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology, Inc. is 2.21x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.